GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,664 | +33.3% | 40,450 | 0.0% | 0.00% | +100.0% |
| Q2 2023 | $58,248 | -31.4% | 40,450 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $84,945 | +83.6% | 40,450 | -1.2% | 0.00% | +100.0% |
| Q4 2022 | $46,274 | -30.9% | 40,950 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $67,000 | +24.1% | 40,950 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $54,000 | -18.2% | 40,950 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $66,000 | -22.4% | 40,950 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $85,000 | -46.5% | 40,950 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $159,000 | +21.4% | 40,950 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $131,000 | +47.2% | 40,950 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $89,000 | -3.3% | 40,950 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $92,000 | -17.1% | 40,950 | -1.2% | 0.00% | -25.0% |
| Q3 2020 | $111,000 | -12.6% | 41,450 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $127,000 | +56.8% | 41,450 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $81,000 | -31.9% | 41,450 | 0.0% | 0.00% | -20.0% |
| Q4 2019 | $119,000 | -21.7% | 41,450 | 0.0% | 0.01% | -28.6% |
| Q3 2019 | $152,000 | -11.6% | 41,450 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $172,000 | -17.7% | 41,450 | +1.2% | 0.01% | -22.2% |
| Q1 2019 | $209,000 | +49.3% | 40,950 | 0.0% | 0.01% | +28.6% |
| Q4 2018 | $140,000 | -17.2% | 40,950 | +45.5% | 0.01% | -12.5% |
| Q3 2018 | $169,000 | -5.6% | 28,154 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $179,000 | +34.6% | 28,154 | 0.0% | 0.01% | +33.3% |
| Q1 2018 | $133,000 | +41.5% | 28,154 | 0.0% | 0.01% | +50.0% |
| Q4 2017 | $94,000 | +56.7% | 28,154 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $60,000 | +1.7% | 28,154 | +16.6% | 0.00% | 0.0% |
| Q2 2017 | $59,000 | +5.4% | 24,154 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $56,000 | +133.3% | 24,154 | 0.0% | 0.00% | +200.0% |
| Q4 2016 | $24,000 | -11.1% | 24,154 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $27,000 | 0.0% | 24,154 | +31.3% | 0.00% | 0.0% |
| Q2 2016 | $27,000 | +3.8% | 18,400 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $26,000 | -13.3% | 18,400 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $30,000 | +30.4% | 18,400 | +84.0% | 0.00% | 0.0% |
| Q3 2015 | $23,000 | -23.3% | 10,000 | -9.9% | 0.00% | -25.0% |
| Q2 2015 | $30,000 | -54.5% | 11,100 | -41.9% | 0.00% | -50.0% |
| Q1 2015 | $66,000 | 0.0% | 19,100 | 0.0% | 0.01% | -33.3% |
| Q4 2014 | $66,000 | -31.2% | 19,100 | 0.0% | 0.01% | -47.8% |
| Q3 2014 | $96,000 | -46.7% | 19,100 | +48.1% | 0.02% | -61.7% |
| Q2 2014 | $180,000 | – | 12,900 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 184,742 | $401,000 | 0.10% |
| Geneos Wealth Management Inc. | 511,606 | $2,261,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $26,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,967 | $41,000 | 0.01% |
| Vivaldi Capital Management LP | 10,668 | $45,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,221,984 | $2,651,000 | 0.01% |
| CENTAURUS FINANCIAL, INC. | 15,614 | $34,000 | 0.00% |
| WEDBUSH SECURITIES INC | 17,998 | $39,000 | 0.00% |
| D.A. DAVIDSON & CO. | 65,310 | $142,000 | 0.00% |
| Virtu Financial LLC | 14,683 | $32,000 | 0.00% |